Literature DB >> 10325381

Detection of antibodies to hepatitis C virus in dried blood spot samples from mothers and their offspring in Lahore, Pakistan.

S P Parker1, H I Khan, W D Cubitt.   

Abstract

Dried blood spot samples from mothers and their offspring attending the obstetric and pediatric departments of two hospitals in Lahore, Pakistan, were tested for antibodies to hepatitis C virus (HCV). The seroprevalence of HCV in the women was 6.7% (95% confidence interval [CI], 4.3 to 9.1), and that in the children was 1.3% (95% CI, 0.34 to 2.26). Four anti-HCV immunoglobulin G (IgG)-positive children had mothers that were anti-HCV IgG negative, which suggested that their infection was community acquired.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325381      PMCID: PMC85032     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Diversity of genotypes of hepatitis C virus in southern India.

Authors:  T Valliammai; S P Thyagarajan; A J Zuckerman; T J Harrison
Journal:  J Gen Virol       Date:  1995-03       Impact factor: 3.891

2.  Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi, Pakistan.

Authors:  S Abdul Mujeeb; Q Jamal; R Khanani; N Iqbal; S Kaher
Journal:  Trop Doct       Date:  1997-01       Impact factor: 0.731

3.  A method for the detection and confirmation of antibodies to hepatitis C virus in dried blood spots.

Authors:  S P Parker; W D Cubitt; A E Ades
Journal:  J Virol Methods       Date:  1997-11       Impact factor: 2.014

4.  The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma.

Authors:  C Y Tong; R Khan; N J Beeching; W U Tariq; C A Hart; N Ahmad; I A Malik
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

5.  Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes.

Authors:  S P Parker; M B Taylor; A E Ades; W D Cubitt; C Peckham
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

6.  The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan.

Authors:  S P Luby; K Qamruddin; A A Shah; A Omair; O Pahsa; A J Khan; J B McCormick; F Hoodbhouy; S Fisher-Hoch
Journal:  Epidemiol Infect       Date:  1997-12       Impact factor: 2.451

7.  Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan.

Authors:  H A Shah; W Jafri; I Malik; L Prescott; P Simmonds
Journal:  J Gastroenterol Hepatol       Date:  1997-11       Impact factor: 4.029

8.  Hepatitis A, B and C seroprevalence in Pakistan.

Authors:  M Agboatwalla; S Isomura; K Miyake; T Yamashita; T Morishita; D S Akram
Journal:  Indian J Pediatr       Date:  1994 Sep-Oct       Impact factor: 1.967

9.  Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.

Authors:  J A Neville; L E Prescott; V Bhattacherjee; N Adams; I Pike; B Rodgers; A El-Zayadi; S Hamid; G M Dusheiko; A A Saeed; G H Haydon; P Simmonds
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

10.  Genotype determination of hepatitis C virus from northern India: identification of a new subtype.

Authors:  A K Panigrahi; J Roca; S K Acharya; S Jameel; S K Panda
Journal:  J Med Virol       Date:  1996-02       Impact factor: 2.327

  10 in total
  19 in total

1.  Use of a dry-plasma collection device to overcome problems with storage and transportation of blood samples for epidemiology studies in developing countries.

Authors:  Z Z Nurgalieva; R Almuchambetova; A Machmudova; D Kapsultanova; M S Osato; J Peacock; R P Zoltek; P A Marchildon; D Y Graham; A Zhangabylov
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

Review 2.  Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies.

Authors:  Kobus Herbst; Matthew Law; Pascal Geldsetzer; Frank Tanser; Guy Harling; Till Bärnighausen
Journal:  Curr Opin HIV AIDS       Date:  2015-11       Impact factor: 4.283

Review 3.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors.

Authors:  Yasir Waheed; Talha Shafi; Sher Zaman Safi; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

5.  Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.

Authors:  Saba Khaliq; Shah Jahan; Bushra Ijaz; Waqar Ahmad; Sultan Asad; Asim Pervaiz; Baila Samreen; Mahwish Khan; Sajida Hassan
Journal:  Virol J       Date:  2010-11-13       Impact factor: 4.099

Review 6.  Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors.

Authors:  Syed Asad Ali; Rafe M J Donahue; Huma Qureshi; Sten H Vermund
Journal:  Int J Infect Dis       Date:  2008-10-02       Impact factor: 3.623

Review 7.  Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data.

Authors:  Muhammad Umer; Mazhar Iqbal
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

8.  Hepatitis B assays in serum, plasma and whole blood on filter paper.

Authors:  Theodor K Mayer; Roberto L Vargas; Ann E Knebel; Scott A Williams; Sean P Culver; Daniel M Clark; Louise R King
Journal:  BMC Clin Pathol       Date:  2012-05-20

9.  In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus.

Authors:  Tariq Javed; Usman Ali Ashfaq; Sana Riaz; Sidra Rehman; Sheikh Riazuddin
Journal:  Virol J       Date:  2011-01-19       Impact factor: 4.099

10.  Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs.

Authors:  Saba Khaliq; Shah Jahan; Asim Pervaiz; Usman Ali Ashfaq; Sajida Hassan
Journal:  Virol J       Date:  2011-05-13       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.